Abstract:Abstract Since the appearance of the first case of coronavirus disease 2019 (COVID-19) a pandemic has emerged affecting millions of individuals worldwide. Although the main clinical manifestations are respiratory, an increase in neurological conditions, specifically acute cerebrovascular disease, has been detected. We present cerebrovascular disease case incidence in hospitalized patients with SARS-CoV-2 infection. Patients were confirmed by microbiological/serological testing, or on chest CT semiology. Available data on co-morbidity, laboratory parameters, treatment administered, neuroimaging, neuropathological studies and clinical evolution during hospitalization, measured by the modified Rankin scale, were analysed. A bivariate study was also designed to identify differences between ischaemic and haemorrhagic subtypes. A statistical model of binary logistic regression and sensitivity analysis was designed to study the influence of independent variables over prognosis. In our centre, there were 1683 admissions of patients with COVID-19 over 50 days, of which 23 (1.4%) developed cerebrovascular disease. Within this group of patients, cerebral and chest CT scans were performed in all cases, and MRI in six (26.1%). Histological samples were obtained in 6/23 cases (two brain biopsies, and four arterial thrombi). Seventeen patients were classified as cerebral ischaemia (73.9%, with two arterial dissections), five as intracerebral haemorrhage (21.7%), and one leukoencephalopathy of posterior reversible encephalopathy type. Haemorrhagic patients had higher ferritin levels at the time of stroke (1554.3 versus 519.2, P = 0.004). Ischaemic strokes were unexpectedly frequent in the vertebrobasilar territory (6/17, 35.3%). In the haemorrhagic group, a characteristic radiological pattern was identified showing subarachnoid haemorrhage, parieto-occipital leukoencephalopathy, microbleeds and single or multiple focal haematomas. Brain biopsies performed showed signs of thrombotic microangiopathy and endothelial injury, with no evidence of vasculitis or necrotizing encephalitis. The functional prognosis during the hospital period was unfavourable in 73.9% (17/23 modified Rankin scale 4–6), and age was the main predictive variable (odds ratio = 1.5; 95% confidence interval 1.012–2.225; P = 0.043). Our series shows cerebrovascular disease incidence of 1.4% in patients with COVID-19 with high morbidity and mortality. We describe pathological and radiological data consistent with thrombotic microangiopathy caused by endotheliopathy with a haemorrhagic predisposition.

Cerebral microbleeds in patients with COVID-19: is there an inevitable connection?

Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon?

COVID-19-associated cerebral microbleeds in the general population

COVID-19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients

The Association of Cerebrovascular Disease with Adverse Outcomes in COVID-19 Patients: A Meta-Analysis Based on Adjusted Effect Estimates

Cerebral Microbleeds Assessment and Quantification in COVID-19 Patients With Neurological Manifestations

Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses

Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description

SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations

Neurological Complications of COVID-19: A Systematic Review of Literature

Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations

Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series

Manifestations and Outcomes of Intracerebral Hemorrhage During the COVID-19 Pandemic in China: Multicenter, Longitudinal Cohort Study

Abstract TMP20: Cerebrovascular Injury Associated With COVID-19 And Non-COVID-19 Acute Respiratory Distress Syndrome

Incidence of cerebrovascular disease as a comorbidity in patients with COVID-19: A meta-analysis

COVID-19 and cerebrovascular diseases: a comprehensive overview

Cerebral Micro-Structural Changes in COVID-19 Patients: an MRI-Based Preliminary Study

Insights Into Neuroimaging Findings Of Patients With Coronavirus Disease 2019 Presenting With Neurological Manifestations

Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study

Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms

COVID-19 and Cerebrovascular Disease